Home > Insider Trading > Filing (0001093557-20-000189)

Filing Details

Accession Number:: 0001093557-20-000189
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-15 18:00:31
Reporting Period:: 2020-06-11

Accepted Time:: 2020-06-15 18:00:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1700255	Steven Jacob Leach	6340 Sequence Drive San Diego CA 92121	Evp Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-06-11	1,700	$372.97	124,798	No	4	S	Direct
Common Stock	Disposition	2020-06-11	2,600	$374.30	122,198	No	4	S	Direct
Common Stock	Disposition	2020-06-11	1,800	$375.68	120,398	No	4	S	Direct
Common Stock	Disposition	2020-06-11	3,481	$376.78	116,917	No	4	S	Direct
Common Stock	Disposition	2020-06-11	7,466	$377.98	109,451	No	4	S	Direct
Common Stock	Disposition	2020-06-11	1,982	$379.42	107,469	No	4	S	Direct
Common Stock	Disposition	2020-06-11	100	$380.06	107,369	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,824	Indirect	Family Holdings

Footnotes

On March 13, 2020, the reporting person adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $372.636 to $373.08. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Included in this number are 31,770 unvested restricted stock units, 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 9,991 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 10,031 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
This transaction was executed in multiple trades at prices ranging from $373.97 to $374.87. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $375.27 to $376.261. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $376.275 to $377.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $377.44 to $378.34. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $379.00 to $379.91. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.